On this page

Sterile Water

Water · Irrigant

Prescription NDA TE AT RLD Official labelling
Informational index, not medical advice. Content is reproduced from public FDA and NLM data. Always confirm against the manufacturer's current prescribing information. Report adverse events to FDA MedWatch.

Overview

Brand name
Sterile Water
Generic name
Water
Dosage form
Irrigant
Route
Irrigation
Marketing category
NDA · NDA
Labeler
B. Braun Medical Inc.
Product type
Human Prescription Drug
DEA schedule
Not scheduled
Active ingredients
2
NDC product codes
5
Packages
13
Data completeness
83% of corroborating sources present

Active ingredients

Source: NDC Directory
Active ingredients and strengths as listed in the NDC Directory.
Ingredient Strength RxCUI Monograph
Water 1 mL/mL 1053154 View
Water 100 mL/100mL 1053154 View

Forms, strengths and routes

Source: NDC Directory
Dosage form
Irrigant
Route of administration
Irrigation
Presentations
18

Regulatory status

Source: Drugs@FDANDC Directory
Application number
016734
Application type
NDA · New Drug Application
Approval date
September 10, 1970
Sponsor
B BRAUN
Products on application
1
Submissions recorded
43
Products approved under application 016734.
Product Trade name Form Strength Ingredient Status TE Flags
016734-001 STERILE WATER IN PLASTIC CONTAINER LIQUID STERILE WATER FOR IRRIGATION Prescription AT RLD

Therapeutic equivalence

Source: Orange Book
TE code
AT
Reference Listed Drug
Yes
Reference Standard
No

What this rating means: Therapeutically equivalent — bioequivalence demonstrated (topical dermatological products)

Codes beginning with “A” indicate products the FDA considers therapeutically equivalent. Codes beginning with “B” indicate bioequivalence has not been established. See methodology.

Approval history

Source: Drugs@FDA
Most recent submissions on application 016734.
Type No. Action Status Date Review
Supplement 49 Manufacturing (CMC) Approved March 30, 2015 Standard
Supplement 48 Manufacturing (CMC) Approved May 8, 2013 Standard
Supplement 44 Manufacturing (CMC) Approved July 8, 2002 Standard
Supplement 43 Manufacturing (CMC) Approved April 3, 2002 Standard
Supplement 42 Manufacturing (CMC) Approved April 12, 2000 Standard
Supplement 41 Manufacturing (CMC) Approved March 25, 1998 Standard
Supplement 40 Manufacturing (CMC) Approved September 11, 1990 Standard
Supplement 38 Manufacturing (CMC) Approved April 19, 1988 Standard
Supplement 34 Manufacturing (CMC) Approved March 5, 1987 Standard
Supplement 36 Manufacturing (CMC) Approved August 30, 1985 Standard
Supplement 35 Labeling Approved July 17, 1985 —
Supplement 32 Manufacturing (CMC) Approved May 17, 1985 Standard
Supplement 31 Manufacturing (CMC) Approved May 15, 1985 Standard
Supplement 33 Manufacturing (CMC) Approved April 3, 1985 Standard
Supplement 30 Labeling Approved October 12, 1982 —
Supplement 27 Manufacturing (CMC) Approved November 6, 1981 Standard
Supplement 26 Labeling Approved October 27, 1981 —
Supplement 25 Manufacturing (CMC) Approved October 27, 1981 Standard
Supplement 28 Manufacturing (CMC) Approved September 28, 1981 Standard
Supplement 29 Manufacturing (CMC) Approved September 24, 1981 Standard
Supplement 20 Labeling Approved March 3, 1981 —
Supplement 24 Manufacturing (CMC) Approved July 16, 1980 Standard
Supplement 23 Manufacturing (CMC) Approved February 15, 1980 Standard
Supplement 17 Labeling Approved January 4, 1980 —
Supplement 22 Labeling Approved September 25, 1979 —
Supplement 21 Manufacturing (CMC) Approved September 24, 1979 Standard
Supplement 19 Labeling Approved July 20, 1979 —
Supplement 18 Manufacturing (CMC) Approved April 26, 1979 Standard
Supplement 13 Labeling Approved December 27, 1978 —
Supplement 12 Manufacturing (CMC) Approved December 27, 1978 Standard
Supplement 15 Manufacturing (CMC) Approved October 27, 1978 Standard
Supplement 14 Manufacturing (CMC) Approved October 27, 1978 Standard
Supplement 16 Manufacturing (CMC) Approved August 3, 1978 Standard
Supplement 11 Manufacturing (CMC) Approved May 26, 1978 Standard
Supplement 10 Manufacturing (CMC) Approved March 6, 1978 Standard
Supplement 9 Manufacturing (CMC) Approved January 19, 1978 Standard
Supplement 8 Manufacturing (CMC) Approved February 4, 1977 Standard
Supplement 7 Labeling Approved August 31, 1976 —
Supplement 6 Manufacturing (CMC) Approved April 2, 1976 Standard
Supplement 5 Manufacturing (CMC) Approved April 2, 1976 Standard
Supplement 4 Manufacturing (CMC) Approved April 2, 1976 Standard
Supplement 3 Labeling Approved September 4, 1974 —
Original application 1 Type 5 - New Formulation or New Manufacturer Approved September 10, 1970 Standard

Prescribing information

Source: openFDA Drug Labeling

Reproduced verbatim from the Structured Product Labeling submitted to the FDA (effective 20251102). This is the manufacturer's labelling text, not a summary and not advice.

HUMAN PRESCRIPTION DRUG · 20251102 HUMAN PRESCRIPTION DRUG · 20210809 HUMAN PRESCRIPTION DRUG · 20171017

Indications and Usage

openFDA Drug Labeling

INDICATIONS AND USAGE Sterile Water for Irrigation USP is indicated for use as an irrigating fluid or pharmaceutic aid. Sterile Water may also be used as an adjunct in the preparation of non-intravenously administered nutrient mixtures (see DOSAGE AND ADMINISTRATION ).

Dosage and Administration

openFDA Drug Labeling

2 DOSAGE AND ADMINISTRATION • For Irrigation only. Not for injection or infusion by usual parenteral routes. ( 2.1 , 5.1 ) • The volume and/or rate of irrigation depend on the type of the procedure and the capacity or the surface area of the structure to be irrigated. ( 2.2 ) • For preparation and administration instructions see the full prescribing information. ( 2.1 , 2.3 ) 2.1 Important Administration Instructions • For irrigation only. Not for intravenous injection. • Sterile Water for Irrigation is hypotonic with an osmolarity of zero mOsmol/L. It is intended for use as an irrigation fluid and not for intravenous administration or administration by other, parenteral routes (e.g., subcutaneous or intramuscular) [see Warnings and Precautions (5.1) ]. • Sterile Water for Irrigation is not potable water and is not intended for oral administration. • Sterile Water for Irrigation that has been warmed must not be returned to storage. 2.2 Recommended Dosage The volume and/or rate of irrigation depend on the type of the procedure and the capacity or the surface area of the structure to be irrigated. 2.3 Preparation and Administration Instructions For single-dose only. Sterile Water for Irrigation is available in a flexible plastic container and a plastic pour bottle. Use the contents of the opened container immediately to minimize the potential for bacterial growth and pyrogen formation. Discard the unused contents of opened containers, as Sterile Water for Irrigation contains no antimicrobial preservative. Adding Medications to Either the Flexible Plastic Container or the Plastic Pour Bottle • Use aseptic technique when making additions to Sterile Water for Irrigation. • Additives may be incompatible with Sterile Water for Irrigation. • The compatibility of additives with Sterile Water for Irrigation must be assessed. Before introducing additives, check for a possible color change and/or the appearance of precipitates, insoluble complexes, or crystals. • Before adding a substance or medication, verify that it is soluble and/or stable in water and that the pH range of Sterile Water for Irrigation is appropriate. • Additives known or determined to be incompatible should not be used. • Mix thoroughly after additives have been introduced. • Use immediately. Administration Instructions for Irrigation by Gravity Using the Flexible Plastic Container 1. Use aseptic technique. 2. Tear overwrap down side at slit and remove solution container. Visually inspect the container. If the outlet port protector is damaged, detached, or not present, discard container as solution path sterility may be impaired. Some opacity of the plastic due to moisture absorption during the sterilization process may be observed. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually. Check for minute leaks by squeezing the container firmly. If leaks are found, discard solution as sterility may be impaired. 3. Suspend container using hanger hole. 4. Remove plastic protector from outlet port at bottom of container. 5. Attach irrigation set. Refer to complete directions accompanying set. Warming If desired, warm the flexible plastic container in overwrap to near body temperature in a water bath or fluid warmer heated to not more than 45°C. Microwave heating of irrigation fluids is not recommended. Administration Using the Plastic Pour Bottle 1. Inspect Sterile Water for Irrigation visually for particulate matter and discoloration prior to use. Discard if the fluid is not clear or the seal is broken. 2. Use aseptic technique 3. Remove the plastic shrink band by tearing along the perforation line and unscrew the bottle cap. 4. Prevent contact of the fluid with the external surface of the container (including the thread for the bottle cap of the plastic pour bottle). Warming If desired, warm the plastic pour bottle in a fluid warmer to not more than 50°C for a maximum of 60 days. Discard after 60 days of warming. Microwave …

Dosage Forms and Strengths

openFDA Drug Labeling

3 DOSAGE FORMS AND STRENGTHS Irrigation: • 250, 500, 1000, and 1500 mL sterile water for irrigation in a single-dose plastic pour bottle • 1000, 2000 and 3000 mL sterile water for irrigation in a single-dose flexible plastic container • 250, 500, 1000, and 1500 mL sterile water for irrigation in a single-dose plastic pour bottle. ( 3 ) • 1000, 2000 and 3000 mL sterile water for irrigation in a single-dose flexible plastic container. ( 3 )

Contraindications

openFDA Drug Labeling

CONTRAINDICATIONS NOT FOR INJECTION BY USUAL PARENTERAL ROUTES.

Warnings and Cautions

openFDA Drug Labeling

5 WARNINGS AND PRECAUTIONS • Hypotonicity : Administration by parenteral routes can result in serious adverse reactions. For irrigation use only. ( 5.1 ) • Excessive Water Absorption : May result in hyponatremia, hypoosmolality and fluid overload. Monitor patients for absorption of clinically relevant amounts of fluid during and after the procedure. Additional monitoring is recommended for patients at increased risk of developing complications of fluid overload syndrome (e.g., patients with renal or cardiac impairment) or hyponatremic encephalopathy (e.g., pediatric patients; women, in particular premenopausal women; patients with hypoxemia; and patients with central nervous system disease). Avoid use in procedures that require longer irrigation times or an irrigation fluid pressure that promotes absorption. ( 5.2 , 8.4 ) • Use with Electrosurgery/Cautery : Ensure compatibility with equipment used with electrosurgery or cautery. ( 5.2 ) 5.1 Hypotonicity Sterile Water for Irrigation is hypotonic with an osmolarity of zero mOsmol/L. It is intended for use as irrigation fluid and not for intravenous administration or administration by other, usual parenteral routes, such as intravascular administration in general, subcutaneous administration, or intramuscular administration. Serious adverse reactions, including cerebral or pulmonary edema, massive hemolysis, and acute renal failure can result from the hypotonicity of Sterile Water for Irrigation [see Warnings and Precautions (5.2) ]. 5.2 Excessive Water Absorption Due to the hypotonicity, absorption of Sterile Water for Irrigation can result in serious adverse reactions of hyponatremia, hypoosmolality and fluid overload, resulting in fatality or permanent morbidity. Complications include cerebral edema, encephalopathy, pulmonary edema, massive hemolysis, rhabdomyolysis, renal failure, and hyperkalemia [see Adverse Reactions (6) ]. In addition, excessive volume or pressure of the irrigation fluid may also cause undue distension of body cavities and may cause tissue disruption (e.g., tears or perforation). These complications can manifest after irrigation has ended and immediate intervention may be required. Monitor patients closely for absorption of clinically relevant amounts of fluid during and for an appropriate period after the procedure. If absorption occurs, discontinue Sterile Water for Irrigation. Additional close monitoring during and/or after the procedure is recommended for patients at increased risk for developing complications related to hypotonicity, such as: • fluid overload syndrome, including patients with severe renal impairment, impaired cardiac function, or other clinical conditions associated with edematous states. • hyponatremic encephalopathy, including pediatric patients; women, in particular premenopausal women; patients with hypoxemia; and patients with underlying central nervous system disease. Avoid use of Sterile Water for Irrigation in patients with wounds where significant absorption may occur, such as procedures that require irrigation over a longer period of time or an irrigation fluid pressure that promotes absorption (e.g., transurethral resection of prostate). Sterile Water for Irrigation should only be used by clinicians familiar with the treatment of possible complications. 5.3 Use with Electrosurgery/Cautery In contrast to other irrigation fluids containing electrolytes, Sterile Water for Irrigation is non-conductive. Therefore, when choosing the distension solution/fluid used with electrosurgery or cautery, ensure compatibility with the equipment.

WARNINGS FOR IRRIGATION ONLY. This preparation is solute-free and its entry into the circulation will cause hemolysis. Solutions for urologic irrigation must be used with caution in patients with severe cardiopulmonary or renal dysfunction. Irrigating fluids used during transurethral prostatectomy have been demonstrated to enter the systemic circulation in relatively large volumes, thus, Sterile Water for Irrigation, USP must be regarded as a systemic drug. Absorption of large amounts of Sterile Water for Irrigation, USP with or without additives can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, overhydration, congested states or pulmonary edema. The risk of dilutional states is inversely proportional to the electrolyte concentrations of administered solutions. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations of such solutions. Do not heat container over 66°C (150°F).

Adverse Reactions

openFDA Drug Labeling

6 ADVERSE REACTIONS The following adverse reactions have been identified during post approval use of Sterile Water for Irrigation. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Metabolism and Nutrition disorders : Hyponatremia, fluid overload, fluid absorption, electrolyte imbalance Nervous System Disorders : Cerebral edema General Disorders and Administration Site Conditions : Burning sensation (with irrigation of eyes and skin wounds) Musculoskeletal and Connective Tissue Disorders : Rhabdomyolysis (myoglobinuria) Renal and Urinary Disorders : Renal failure Other Adverse reactions which may occur in association with absorption of water for irrigation include: Blood and Lymphatic System Disorders : Hemolysis (hemoglobinemia, hemoglobinuria) Metabolism and Nutrition Disorders : Hypervolemia, hypoosmolality, hyperkalemia, acid/base balance disorder Nervous System Disorders : Encephalopathy (seizure, loss of vision, lethargy, disorientation, irritability, vomiting, nausea, headache) Cardiac Disorders : Cardiac arrest, cardiac failure, bradycardia, electrocardiogram abnormal Vascular Disorders : Hypertension, postoperative hypotension Respiratory, Thoracic and Mediastinal Disorders: Respiratory arrest, respiratory failure, pulmonary edema Most common adverse reactions are: hyponatremia, fluid overload, fluid absorption, electrolyte imbalance. ( 6 ) To report SUSPECTED ADVERSE REACTIONS, contact Baxter Healthcare Corporation at 1-866-888-2472 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Use in Specific Populations

openFDA Drug Labeling

8 USE IN SPECIFIC POPULATIONS 8.1 Pregnancy Risk Summary Appropriate administration of Sterile Water for Irrigation is not expected to cause adverse developmental outcomes. There are no available data on Sterile Water for Irrigation use in pregnant women to determine a drug-associated risk of adverse developmental outcomes. Animal reproduction studies have not been conducted with Sterile Water for Irrigation. All pregnancies have a background risk of birth defect, loss, or other adverse outcomes. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20% respectively. 8.2 Lactation Risk Summary Appropriate administration of Sterile Water for Irrigation is not expected to cause harm to a breastfed infant. There are no data on the presence of Sterile Water for Irrigation in either human or animal milk, the effects on the breastfed infant or the effects on milk production. The lack of clinical data during lactation precludes a clear determination of the risk of Sterile Water for Irrigation to a breastfed infant; therefore, the developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for Sterile Water for Irrigation and any potential adverse effects on the breastfed infant from Sterile Water for Irrigation or from the underlying maternal condition. 8.4 Pediatric Use Safety and effectiveness in pediatric patients have not been established. Pediatric patients are at higher risk compared to adults for developing encephalopathy as a complication of hyponatremia, if there is excessive absorption of Sterile Water for Irrigation [see Warnings and Precautions (5.2) ]. 8.5 Geriatric Use Sterile Water for Irrigation should be used cautiously in older patients. Geriatric patients are more likely to have decreased cardiac, renal, or hepatic function, and other diseases or concomitant drug therapy.

Description

openFDA Drug Labeling

DESCRIPTION Sterile Water for Irrigation, USP is a sterile, distilled, nonpyrogenic water for injection intended only for sterile irrigation, washing, rinsing and dilution purposes. pH 5.5 (5.0 to 7.0). Sterile Water for Irrigation, USP contains no bacteriostat, antimicrobial agent or added buffer and is intended for use only as a single-dose or short procedure irrigation. When smaller volumes are required the unused portion should be discarded. Sterile Water for Irrigation, USP may be classified as a sterile irrigant, wash, rinse, diluent and pharmaceutical vehicle. Water for Irrigation, USP is chemically designated H 2 O. The flexible plastic container is fabricated from a specially formulated polyvinylchloride. Water can permeate from inside the container into the overwrap but not in amounts sufficient to affect the solution significantly. The semi-rigid container is fabricated from a specially formulated polyolefin. It is a copolymer of ethylene and propylene. The container requires no vapor barrier to maintain the proper drug concentration. The flexible plastic container is fabricated from a specially formulated polyvinylchloride. Water can permeate from inside the container into the overwrap but not in amounts sufficient to affect the solution significantly. Solutions in contact with the plastic container may leach out certain chemical components from the plastic in very small amounts; however, biological testing was supportive of the safety of the plastic container materials. Exposure to temperatures above 25°C/77°F during transport and storage will lead to minor losses in moisture content. Higher temperatures lead to greater losses. It is unlikely that these minor losses will lead to clinically significant changes within the expiration period.

10 OVERDOSAGE Excessive rate, volume, pressure or duration of irrigation with hypotonic fluid can result in excessive fluid absorption and permanent morbidity or death as a result of hyponatremia, hypoosmolality and/or fluid overload. In the event of clinically relevant absorption of Sterile Water for Irrigation, immediate intervention may be required [see Warnings and Precautions (5.2) ].

How Supplied / Storage and Handling

openFDA Drug Labeling

HOW SUPPLIED NDC No. Product Container Size (mL) Container Type 0409-6139-22 Manufactured for ICU Medical, Inc., Lake Forest, Illinois, 60045, USA 0990-6139-22 Sterile Water for Irrigation USP 250 Semi-Rigid Irrigation 0409-6139-03 0990-6139-03 Sterile Water for Irrigation USP 500 Semi-Rigid Irrigation 0409-7139-09 0990-7139-09 Sterile Water for Irrigation USP 1000 Semi-Rigid Irrigation 0409-7139-36 0990-7139-36 Sterile Water for Irrigation USP 1500 Semi-Rigid Irrigation 0409-7973-05 Manufactured by ICU Medical, Inc., Lake Forest, Illinois, 60045, USA 0990-7973-05 Sterile Water for Irrigation USP 1000 Flexible Irrigation 0409-7973-07 0990-7973-07 Sterile Water for Irrigation USP 2000 Flexible Irrigation 0409-7973-08 0990-7973-08 Sterile Water for Irrigation USP 3000 Flexible Irrigation ICU Medical is transitioning NDC codes from the "0409" to a "0990" labeler code. Both NDC codes are expected to be in the market for a period of time. Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.] Protect from freezing. Revised: July, 2018 ICU Medical, Inc., Lake Forest, Illinois, 60045, USA EN-4662

Adverse event reports

Source: openFDA FAERS
19,134
FAERS reports mentioning this drug
as of 2026-09-25T03:42:24+00:00
A report count is not a risk measure. FAERS accepts voluntary and mandatory reports without establishing causation, and reporting is influenced by how widely a drug is used, how long it has been marketed, and media attention. FDA states that reports “do not prove that the drug caused the event”. Compare rates, not totals.

Attributed to this product's most-reported active ingredient: WATER. Combination products with more than six active ingredients are not attributed, because a report count summed across a long ingredient list measures the list, not the medicine.

Recalls

Source: FDA Enforcement
Drug recall enforcement reports associated with this product.
Classification Reported Firm Reason Status
Class II February 4, 2026 Baxter Healthcare Corporation Presence of particulate matter: plastic particles from the bottle rim were observed floating into the solution Ongoing

Packaging and NDCs

Source: NDC Directory
Every National Drug Code package associated with this medication. The NDC is the identifier used for dispensing, billing and pharmacovigilance in the United States.
Package NDC Product NDC Labeler Description Marketing start
0264-2101-00 0264-2101 B. Braun Medical Inc. 16 CONTAINER in 1 CASE (0264-2101-00) / 1000 mL in 1 CONTAINER September 10, 1970
0264-2101-10 0264-2101 B. Braun Medical Inc. 16 CONTAINER in 1 CASE (0264-2101-10) / 500 mL in 1 CONTAINER September 10, 1970
0264-7386-50 0264-7386 B. Braun Medical Inc. 4 CONTAINER in 1 CASE (0264-7386-50) / 2000 mL in 1 CONTAINER September 13, 2013
0264-7386-60 0264-7386 B. Braun Medical Inc. 4 CONTAINER in 1 CASE (0264-7386-60) / 3000 mL in 1 CONTAINER September 13, 2013
0338-0003-44 0338-0003 Baxter Healthcare Corporation 14 BAG in 1 CARTON (0338-0003-44) / 1000 mL in 1 BAG May 30, 1980
0338-0003-46 0338-0003 Baxter Healthcare Corporation 6 BAG in 1 CARTON (0338-0003-46) / 2000 mL in 1 BAG May 30, 1980
0338-0003-47 0338-0003 Baxter Healthcare Corporation 4 BAG in 1 CARTON (0338-0003-47) / 3000 mL in 1 BAG May 30, 1980
0338-0004-02 0338-0004 Baxter Healthcare Corporation 24 BOTTLE, PLASTIC in 1 CARTON (0338-0004-02) / 250 mL in 1 BOTTLE, PLASTIC December 31, 1974
0338-0004-03 0338-0004 Baxter Healthcare Corporation 18 BOTTLE, PLASTIC in 1 CARTON (0338-0004-03) / 500 mL in 1 BOTTLE, PLASTIC December 31, 1974
0338-0004-04 0338-0004 Baxter Healthcare Corporation 12 BOTTLE, PLASTIC in 1 CARTON (0338-0004-04) / 1000 mL in 1 BOTTLE, PLASTIC December 31, 1974
0990-7973-05 0990-7973 ICU Medical Inc. 12 POUCH in 1 CASE (0990-7973-05) / 1 BAG in 1 POUCH / 1000 mL in 1 BAG September 1, 2019
0990-7973-07 0990-7973 ICU Medical Inc. 6 POUCH in 1 CASE (0990-7973-07) / 1 BAG in 1 POUCH / 2000 mL in 1 BAG October 1, 2019
0990-7973-08 0990-7973 ICU Medical Inc. 4 POUCH in 1 CASE (0990-7973-08) / 1 BAG in 1 POUCH / 3000 mL in 1 BAG August 1, 2019
0264-2101 0264-2101 B. Braun Medical Inc. — September 10, 1970
0264-7386 0264-7386 B. Braun Medical Inc. — September 13, 2013
0338-0003 0338-0003 Baxter Healthcare Corporation — May 30, 1980
0338-0004 0338-0004 Baxter Healthcare Corporation — December 31, 1974
0990-7973 0990-7973 ICU Medical Inc. — August 1, 2019

Sources for this page

Every dataset that contributed a fact to this page.
Dataset Agency Used for
NDC Directory FDA Identity, ingredients, strengths, forms, routes, labelers, packages
Drugs@FDA FDA Application, sponsor, submissions, review documents, marketing status
Orange Book FDA Therapeutic equivalence codes, reference drug flags, patents, exclusivity
Drug Labeling FDA / NLM Prescribing information reproduced above
FAERS FDA Adverse event report counts
Enforcement FDA Recall records

Generated September 25, 2026 · 12 sections on this page.